Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Minerva Neurosciences
AddedFeb 19, 2024
UpdatedJun 18, 2026
Minerva Neurosciences

Minerva Neurosciences

Public

Minerva Neurosciences, a US-based biopharmaceutical firm, develops therapies for CNS and neuropsychiatric diseases.

HQ
Waltham, MA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Minerva Neurosciences, founded in Waltham, United States, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for central nervous system (CNS) and neuropsychiatric diseases. The company's core mission is to improve the lives of patients suffering from conditions such as schizophrenia and Parkinson's disease. Minerva's product pipeline includes promising drug candidates like Roluperidone (MIN-101), aimed at addressing unmet medical needs in these therapeutic areas.

Notable figures associated with Minerva Neurosciences include its experienced leadership team and board of directors, who bring extensive expertise in biotechnology and pharmaceuticals. The company has garnered attention from investors and the medical community for its innovative approach to treating CNS disorders. Key achievements include advancing their drug candidates through various stages of clinical trials, demonstrating potential efficacy and safety. Minerva's impact lies in its commitment to pioneering new treatments that could significantly enhance patient outcomes in neuropsychiatric care.

Minerva Neurosciences - Similar Companies

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Minerva Biotechnologies logo

Minerva Biotechnologies

minervabio.com

Intellect Neurosciences logo

Intellect Neurosciences

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Neuraly logo

Neuraly

neuralymed.com

MentiNova logo

MentiNova

Psy Therapeutics logo

Psy Therapeutics

psythx.com

Neurolixis logo

Neurolixis

neurolixis.com

Neurovia logo

Neurovia

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

Marinus Pharmaceuticals logo

Marinus Pharmaceuticals

marinuspharma.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

NeurOp logo

NeurOp

Cerevance logo

Cerevance

cerevance.com

Minerva Neurosciences - Quick Facts

Who are Minerva Neurosciences' competitors?

Companies similar to Minerva Neurosciences include Neurana Pharmaceuticals, Minerva Biotechnologies, Intellect Neurosciences and Reservoir Neuroscience.

When was Minerva Neurosciences founded?

Minerva Neurosciences was founded in 2007.

Where is Minerva Neurosciences' headquarters located?

Minerva Neurosciences' headquarters is located in Waltham, MA, US.

When was Minerva Neurosciences' last funding round?

Minerva Neurosciences' most recent funding round was for $88k (USD) in December 2019.

How much has Minerva Neurosciences raised to-date?

As of Dec 18, 2019, Minerva Neurosciences has raised a total of $51.3M (USD).

How many employees does Minerva Neurosciences have?

Minerva Neurosciences has 9 employees as of Feb 6, 2024.

Minerva Neurosciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
  • Healthtech
Unique IDs
  • ein: 260784194
  • secCik: 0001598646
  • ticker: NERV
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research